You are here:

1. Homepage
2. Pharmacovigilance
3. Information on Risks

Dear Doctor Letter (Rote-Hand-Brief) on Strattera^® (atomoxetine): Risk of increased blood pressure and/or heart rate

Important safety-relevant information on the risk of increased blood pressure and/or heart rate associated with the use of Strattera^® (atomoxetine) for treatment of Attention Deficit/Hyperactivity Disorder (ADHD).
A  Rote-Hand-Brief on Strattera® (file size: 286 KB) will be circulated.

Additional information (available in German only):

 Änderungen der Fachinformation (file size: 135 KB)

 Leitfaden für Ärzte (file size: 460 KB)

 Verlaufsbogen zur Dokumentation kardiovaskulärer Veränderungen unter ADHS-Medikation (file size: 454 KB)